Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Echothiophate in Pediatric Patients With Refractory Amblyopia
NCT07554131Phase 2Not yet recruiting
- Sponsor
- University of Oklahoma
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of echothiophate in Refractory amblyopia, sponsored by University of Oklahoma. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
echothiophate
03
Conditions
Refractory amblyopia
Beyond the preview
Go deeper on NCT07554131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07554131.